Related Experiment Video
Updated: Aug 11, 2026
04:32
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Ventilator-associated pneumonia or not? Contemporary diagnosis
1University of Texas Medical Branch, Galveston, Texas, USA. cmayhall@utmb.edu
Emerging Infectious Diseases
|April 11, 2001
Summary
Diagnosing ventilator-associated pneumonia (VAP) accurately relies on quantitative culture and microscopy of respiratory secretions. Bronchoscopic techniques like protected specimen brush and bronchoalveolar lavage are the preferred methods for obtaining these samples.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Pulmonary Medicine
Background:
- Ventilator-associated pneumonia (VAP) is a common hospital-acquired infection.
- It affects patients requiring mechanical ventilation for 48 hours or more.
- Accurate diagnosis is crucial for effective treatment.
Purpose of the Study:
- To outline the most accurate diagnostic methods for VAP.
- To emphasize the role of lower respiratory tract sample analysis.
- To discuss the reliability of bronchoscopic techniques.
Main Methods:
- Quantitative culture and microscopy of lower respiratory tract secretions.
- Bronchoscopically directed techniques, including protected specimen brush (PSB) and bronchoalveolar lavage (BAL).
Main Results:
- Quantitative culture and microscopy provide the most accurate VAP diagnosis.
- PSB and BAL demonstrate acceptable repeatability.
- Results are reliable even with concurrent extrapulmonary antibiotic use if therapy is unchanged for 72 hours prior.
Conclusions:
- Bronchoscopic techniques are the gold standard for VAP diagnosis.
- Quantitative analysis of respiratory secretions ensures diagnostic accuracy.
- Understanding methodological nuances improves VAP management.
Related Concept Videos
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...